Composition and method for reducing blood glucose levels

Abstract

The present invention relates to a composition and method for reducing blood glucose levels in a mammal, such as canines and humans. The composition includes bran, cinnamon, yeast, gelatin, and optionally, wheat germ oil, octacosanol, and/or flavor. The method includes administering the composition to the mammal and, if the composition lacks wheat germ oil, also administering wheat germ oil to the mammal.

1 - 9 . (canceled) 
     
     
         10 . A method of reducing a blood glucose level in a subject in need thereof, the method comprising administering to the subject a composition comprising:
 about 10 to about 45 wt-% yeast;   about 10 to about 70 wt-% bran;   about 2 to about 30 wt-% cinnamon; and   about 5 to about 15 wt-% gelatin;   
       wherein administering is effective to lower the required dose of insulin for effective glucose control and to stabilize blood glucose levels. 
     
     
         11 . The method of  claim 10 , wherein the subject also receives insulin to control the blood glucose level. 
     
     
         12 . The method of  claim 11 , comprising administering the composition within one hour after the subject receives a dose of insulin. 
     
     
         13 . The method of  claim 10 , comprising administering the composition within one hour before a meal. 
     
     
         14 . The method of  claim 10 , wherein the composition further comprises an ingredient selected from the group consisting of:
 about 5 to about 15 wt-% wheat germ oil;   about 5 to about 30 wt-% flavoring;   about 0.1 to about 2 wt-% octacosanol;   about 0.5 to about 3 wt-% chromium enhanced yeast; and   a mixture thereof.   
     
     
         15 . The method of  claim 10 , wherein:
 the bran comprises approximately equal amounts of wheat bran and oat bran.   
     
     
         16 . The method of  claim 10 , wherein the composition comprises:
 about 22 wt-% brewers yeast;   about 44 wt-% bran;   about 11 wt-% cinnamon;   about 11 wt-% gelatin; and   
       further comprises about 11 wt-% wheat germ oil. 
     
     
         17 . The method of  claim 10 , wherein the composition comprises:
 about 17 wt-% brewers yeast;   about 34 wt-% bran;   about 9 wt-% cinnamon;   about 9 wt-% gelatin; and   
       further comprises:
 about 9 wt-% wheat germ oil; 
 about 17 wt-% flavoring; and 
 about 0.7 wt-% octacosanol. 
 
     
     
         18 . The method of  claim 10 , wherein the composition comprises:
 about 33 wt-% brewers yeast;   about 38 wt-% bran;   about 19 wt-% cinnamon;   about 9 wt-% gelatin; and   
       further comprises about 1.6 wt-% chromium enhanced yeast. 
     
     
         19 . (canceled) 
     
     
         20 . The method of  claim 10 , wherein the subject is a human. 
     
     
         21 . The method of  claim 10 , wherein the yeast is selected from the group consisting of brewers yeast, chromium enhanced yeast, and a mixture thereof. 
     
     
         22 . The method of  claim 10 , wherein:
 the bran comprises approximately equal amounts of wheat bran and oat bran; and   the yeast is selected from the group consisting of brewers yeast, chromium enhanced yeast, and a mixture thereof.   
     
     
         23 . A method of reducing a blood glucose level in a subject in need thereof, the method comprising administering to the subject a composition comprising:
 about 17 wt-% brewers yeast;   about 34 wt-% bran;   about 9 wt-% cinnamon;   about 9 wt-% gelatin;   about 9 wt-% wheat germ oil;   about 17 wt-% flavoring; and   about 0.7 wt-% octacosanol;   
       wherein administering is effective to lower the required dose of insulin for effective glucose control and to stabilize blood glucose levels. 
     
     
         24 . The method of  claim 23 , wherein the subject is a human. 
     
     
         25 . A method of reducing a blood glucose level in a subject in need thereof, the method comprising administering to the subject a composition comprising:
 about 33 wt-% brewers yeast;   about 38 wt-% bran;   about 19 wt-% cinnamon;   about 9 wt-% gelatin; and   about 1.6 wt-% chromium enhanced yeast;   
       wherein administering is effective to lower the required dose of insulin for effective glucose control and to stabilize blood glucose levels. 
     
     
         26 . The method of  claim 25 , wherein the subject is a human.